Company Filing History:
3 out of 125 
3 out of 2,405 
Years Active: 2020-2023
Title: Gopalan (Raghu) Raghunathan: Innovator in Cognitive Disorder Treatments
Introduction
Gopalan (Raghu) Raghunathan is a notable inventor based in Santa Clara, California. He has made significant contributions to the field of cognitive disorder treatments, holding three patents to his name. His work focuses on innovative methods for utilizing humanized antibodies to address cognitive disorders.
Latest Patents
Raghunathan's latest patents include a humanized antibody for treating or preventing cognitive disorders, along with the processes for producing the same. The invention provides methods for using and compositions of humanized antibodies that bind tau protein that is phosphorylated at the serine at position 413. This groundbreaking work aims to offer new avenues for treating cognitive disorders effectively.
Career Highlights
Throughout his career, Raghunathan has worked with prominent companies such as Teijin Pharma Limited and Merck Sharp & Dohme Corporation. His experience in these organizations has contributed to his expertise in the pharmaceutical and biotechnology sectors.
Collaborations
Raghunathan has collaborated with esteemed colleagues, including Hiroshi H Eguchi and Takashi Murakami. These partnerships have further enriched his research and development efforts in the field of cognitive disorders.
Conclusion
Gopalan (Raghu) Raghunathan is a distinguished inventor whose work in humanized antibodies is paving the way for innovative treatments for cognitive disorders. His contributions to the field are invaluable and continue to inspire advancements in medical science.